Eli Frydman
board of director
cardiology
Lifebond
Israel
Biography
Eli Frydman is a Managing Director – Healthcare for Aurum Ventures MKI. Before joining Aurum, Dr. Frydman served as the Chief Business Officer of FutuRx, the drug development incubator established by J&J, Orbimed and Takeda. Prior to that, he served for 10 years as the COO of Aposense Ltd., (TASE: APOS), with responsibilities for business development, operations and finance. Before joining Aposense, Dr. Frydman served as a Senior Business Development manager at GE Healthcare Europe (based in France), doing healthcare M&A across Europe. Mr. Frydman holds an MBA from the Ecole des Ponts, in Paris, and a PhD in Chemistry (nanotechnology) from the Weizmann Institute of Science. Eli Frydman is a Managing Director – Healthcare for Aurum Ventures MKI. Before joining Aurum, Dr. Frydman served as the Chief Business Officer of FutuRx, the drug development incubator established by J&J, Orbimed and Takeda. Prior to that, he served for 10 years as the COO of Aposense Ltd., (TASE: APOS), with responsibilities for business development, operations and finance. Before joining Aposense, Dr. Frydman served as a Senior Business Development manager at GE Healthcare Europe (based in France), doing healthcare M&A across Europe. Mr. Frydman holds an MBA from the Ecole des Ponts, in Paris, and a PhD in Chemistry (nanotechnology) from the Weizmann Institute of Science.
Research Interest
pharmaceutical industry.
